ES2B-C001

N/A

Report date: 2025/01/09 20:00:05

Base Information

Drug NameES2B-C001
Drug Alias NameES-2B-C001ES-2-B-C-001
ClassificationVaccines
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMetastatic breast cancerBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustria
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAdaptVac
China Registration ClassN/A

Develop Information

Active CompaniesExpreS2 ion BiotechnologiesAdaptVac
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A